vs

Side-by-side financial comparison of Adtalem Global Education Inc. (ATGE) and COMMVAULT SYSTEMS INC (CVLT). Click either name above to swap in a different company.

Adtalem Global Education Inc. is the larger business by last-quarter revenue ($503.4M vs $311.7M, roughly 1.6× COMMVAULT SYSTEMS INC). Adtalem Global Education Inc. runs the higher net margin — 15.2% vs 4.7%, a 10.5% gap on every dollar of revenue. On growth, COMMVAULT SYSTEMS INC posted the faster year-over-year revenue change (13.3% vs 12.4%). COMMVAULT SYSTEMS INC produced more free cash flow last quarter ($131.8M vs $15.1M). Over the past eight quarters, COMMVAULT SYSTEMS INC's revenue compounded faster (17.8% CAGR vs 10.4%).

Adtalem Global Education Inc. is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Commvault Systems, Inc. is an American publicly traded cybersecurity and data protection software company. Commvault's services are used for data security, as well as cloud and infrastructure management.

ATGE vs CVLT — Head-to-Head

Bigger by revenue
ATGE
ATGE
1.6× larger
ATGE
$503.4M
$311.7M
CVLT
Growing faster (revenue YoY)
CVLT
CVLT
+0.9% gap
CVLT
13.3%
12.4%
ATGE
Higher net margin
ATGE
ATGE
10.5% more per $
ATGE
15.2%
4.7%
CVLT
More free cash flow
CVLT
CVLT
$116.7M more FCF
CVLT
$131.8M
$15.1M
ATGE
Faster 2-yr revenue CAGR
CVLT
CVLT
Annualised
CVLT
17.8%
10.4%
ATGE

Income Statement — Q2 FY2026 vs Q4 FY2026

Metric
ATGE
ATGE
CVLT
CVLT
Revenue
$503.4M
$311.7M
Net Profit
$76.4M
$14.6M
Gross Margin
59.2%
81.4%
Operating Margin
22.1%
5.3%
Net Margin
15.2%
4.7%
Revenue YoY
12.4%
13.3%
Net Profit YoY
0.7%
EPS (diluted)
$2.11
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATGE
ATGE
CVLT
CVLT
Q1 26
$311.7M
Q4 25
$503.4M
$313.8M
Q3 25
$462.3M
$276.2M
Q2 25
$457.1M
$282.0M
Q1 25
$466.1M
$275.0M
Q4 24
$447.7M
$262.6M
Q3 24
$417.4M
$233.3M
Q2 24
$409.9M
$224.7M
Net Profit
ATGE
ATGE
CVLT
CVLT
Q1 26
$14.6M
Q4 25
$76.4M
$17.8M
Q3 25
$61.8M
$14.7M
Q2 25
$54.2M
$23.5M
Q1 25
$60.8M
$31.0M
Q4 24
$75.9M
$11.0M
Q3 24
$46.2M
$15.6M
Q2 24
$49.4M
$18.5M
Gross Margin
ATGE
ATGE
CVLT
CVLT
Q1 26
81.4%
Q4 25
59.2%
81.1%
Q3 25
56.6%
80.1%
Q2 25
56.5%
82.0%
Q1 25
57.1%
82.6%
Q4 24
58.3%
81.5%
Q3 24
55.4%
81.6%
Q2 24
55.5%
82.3%
Operating Margin
ATGE
ATGE
CVLT
CVLT
Q1 26
5.3%
Q4 25
22.1%
6.3%
Q3 25
18.5%
4.5%
Q2 25
16.8%
8.9%
Q1 25
19.4%
9.7%
Q4 24
23.2%
5.2%
Q3 24
16.8%
6.4%
Q2 24
16.7%
8.2%
Net Margin
ATGE
ATGE
CVLT
CVLT
Q1 26
4.7%
Q4 25
15.2%
5.7%
Q3 25
13.4%
5.3%
Q2 25
11.9%
8.3%
Q1 25
13.1%
11.3%
Q4 24
16.9%
4.2%
Q3 24
11.1%
6.7%
Q2 24
12.1%
8.2%
EPS (diluted)
ATGE
ATGE
CVLT
CVLT
Q1 26
$0.34
Q4 25
$2.11
$0.40
Q3 25
$1.67
$0.33
Q2 25
$1.43
$0.52
Q1 25
$1.59
$0.68
Q4 24
$1.98
$0.24
Q3 24
$1.18
$0.35
Q2 24
$1.23
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATGE
ATGE
CVLT
CVLT
Cash + ST InvestmentsLiquidity on hand
$56.3M
$900.0M
Total DebtLower is stronger
$504.3M
Stockholders' EquityBook value
$1.4B
$7.5M
Total Assets
$2.6B
$1.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATGE
ATGE
CVLT
CVLT
Q1 26
$900.0M
Q4 25
$56.3M
$1.0B
Q3 25
$264.7M
$1.1B
Q2 25
$199.6M
$363.2M
Q1 25
$219.0M
$302.1M
Q4 24
$194.0M
$243.6M
Q3 24
$264.8M
$303.1M
Q2 24
$219.3M
$287.9M
Total Debt
ATGE
ATGE
CVLT
CVLT
Q1 26
Q4 25
$504.3M
Q3 25
$553.2M
Q2 25
$552.7M
Q1 25
$552.2M
Q4 24
$649.9M
Q3 24
$649.3M
Q2 24
$648.7M
Stockholders' Equity
ATGE
ATGE
CVLT
CVLT
Q1 26
$7.5M
Q4 25
$1.4B
$216.7M
Q3 25
$1.5B
$210.5M
Q2 25
$1.4B
$364.7M
Q1 25
$1.4B
$325.1M
Q4 24
$1.4B
$287.8M
Q3 24
$1.4B
$277.8M
Q2 24
$1.4B
$281.8M
Total Assets
ATGE
ATGE
CVLT
CVLT
Q1 26
$1.9B
Q4 25
$2.6B
$2.0B
Q3 25
$2.9B
$1.9B
Q2 25
$2.8B
$1.2B
Q1 25
$2.8B
$1.1B
Q4 24
$2.7B
$1.0B
Q3 24
$2.8B
$958.5M
Q2 24
$2.7B
$934.9M
Debt / Equity
ATGE
ATGE
CVLT
CVLT
Q1 26
Q4 25
0.37×
Q3 25
0.38×
Q2 25
0.39×
Q1 25
0.39×
Q4 24
0.45×
Q3 24
0.47×
Q2 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATGE
ATGE
CVLT
CVLT
Operating Cash FlowLast quarter
$29.7M
$132.2M
Free Cash FlowOCF − Capex
$15.1M
$131.8M
FCF MarginFCF / Revenue
3.0%
42.3%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
0.39×
9.02×
TTM Free Cash FlowTrailing 4 quarters
$368.0M
$237.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATGE
ATGE
CVLT
CVLT
Q1 26
$132.2M
Q4 25
$29.7M
$4.0M
Q3 25
$130.5M
$76.8M
Q2 25
$59.7M
$31.7M
Q1 25
$207.9M
$77.0M
Q4 24
$-19.0M
$30.1M
Q3 24
$89.3M
$55.6M
Q2 24
$40.6M
$44.7M
Free Cash Flow
ATGE
ATGE
CVLT
CVLT
Q1 26
$131.8M
Q4 25
$15.1M
$1.9M
Q3 25
$114.5M
$73.6M
Q2 25
$40.7M
$29.8M
Q1 25
$197.7M
$76.2M
Q4 24
$-29.7M
$29.9M
Q3 24
$78.9M
$53.7M
Q2 24
$37.4M
$43.8M
FCF Margin
ATGE
ATGE
CVLT
CVLT
Q1 26
42.3%
Q4 25
3.0%
0.6%
Q3 25
24.8%
26.6%
Q2 25
8.9%
10.6%
Q1 25
42.4%
27.7%
Q4 24
-6.6%
11.4%
Q3 24
18.9%
23.0%
Q2 24
9.1%
19.5%
Capex Intensity
ATGE
ATGE
CVLT
CVLT
Q1 26
Q4 25
2.9%
0.7%
Q3 25
3.5%
1.2%
Q2 25
4.2%
0.7%
Q1 25
2.2%
0.3%
Q4 24
2.4%
0.1%
Q3 24
2.5%
0.8%
Q2 24
0.8%
0.4%
Cash Conversion
ATGE
ATGE
CVLT
CVLT
Q1 26
9.02×
Q4 25
0.39×
0.23×
Q3 25
2.11×
5.21×
Q2 25
1.10×
1.35×
Q1 25
3.42×
2.48×
Q4 24
-0.25×
2.74×
Q3 24
1.93×
3.57×
Q2 24
0.82×
2.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATGE
ATGE

Walden University Segment$217.6M43%
Chamberlain University Segment$183.8M37%
Medical And Veterinary$102.0M20%
Other Services$1.6M0%

CVLT
CVLT

Term-based license$114.4M37%
Software-as-a-service$93.1M30%
Customer support$80.9M26%
Other$13.1M4%
Perpetual license$10.1M3%

Related Comparisons